Skip to Content

Ashmore Emerging Markets Sm Cp Eq A ESSAX

Medalist Rating as of | See Ashmore Investment Hub
  • NAV / 1-Day Return 13.38  /  −1.04 %
  • Total Assets 10.1 Mil
  • Adj. Expense Ratio
    1.520%
  • Expense Ratio 1.520%
  • Distribution Fee Level Above Average
  • Share Class Type Front Load
  • Category Diversified Emerging Mkts
  • Investment Style Mid Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.61%
  • Turnover 79%

USD | NAV as of Apr 15, 2024 | 1-Day Return as of Apr 15, 2024, 11:48 PM GMT+0

Morningstar’s Analysis ESSAX

Will ESSAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Ashmore Emerging Markets Sm Cp Eq A earns a Morningstar Medalist Rating of Neutral with strength in areas such as Process offset by weaker spots such as People.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ESSAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 35.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

MY E.G.Services Bhd

5.04 510,386
Technology

Dentium Co Ltd

4.15 420,425
Healthcare

KoMiCo Ltd

4.11 415,800
Technology

PB Fintech Ltd

3.50 354,847
Financial Services

WinWay Technology Co Ltd Ordinary Shares

3.49 353,340
Technology

E Ink Holdings Inc

3.22 326,205
Technology

Granules India Ltd

2.92 296,185
Healthcare

eCloudvalley Digital Technology Co Ordinary Shares

2.92 295,538
Technology

Totvs SA

2.85 288,331
Technology

Oncoclinicas Do Brasil Servicos Medicos SA

2.81 284,076
Healthcare